Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Red Rock Compounding Pharmacy is a specialized pharmaceutical provider based in Utah that focuses on the formulation of customized medications tailored to individual patient needs. The company operates as a compounding pharmacy, offering a diverse range of services including hormone replacement therapy, pain management, and pediatric formulations. In recent years, Red Rock has gained significant industry attention for its production of compounded GLP-1 receptor agonists, such as semaglutide and tirzepatide, particularly during periods of national drug shortages. The pharmacy adheres to strict quality control standards to ensure the safety and potency of its sterile and non-sterile preparations. By bridging the gap between mass-produced pharmaceuticals and personalized medicine, Red Rock serves a critical role for patients requiring specific dosages or delivery methods not available commercially.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Red Rock Compounding Pharmacy.